NR
New Rhein Healthcare
Private EquityModerateNew Rhein Healthcare is a firm that provides investment opportunities to the medical field.
6
Investments
2
Exits
$240M
AUM
33.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for New Rhein Healthcare.
Investment Thesis & Strategy
New Rhein Healthcare, a private equity firm, invests in various stages of companies within the healthcare industry. They seek companies with strong growth potential and the ability to improve patient outcomes.
Investment Activity
Deals per year over the last 1 years
12
2019Portfolio Companies
Selected investments from their portfolio of 6 companies
M
Mallinckrodt
Healthcare · Growth, 2019
P
Par Pharmaceutical
Healthcare · Growth, 2019
I
Impax Laboratories
Healthcare · Growth, 2019
A
Amneal Pharmaceuticals
Healthcare · Growth, 2019
X
Xeris Biopharma
Biotech · Growth, 2019
A
Aytu BioScience
Healthcare · Growth, 2019
C
Catalent
Healthcare · Growth, 2019
T
TherapeuticsMD
Healthcare · Growth, 2019
A
ANI Pharmaceuticals
Healthcare · Growth, 2019
A
Assertio Therapeutics
Healthcare · Growth, 2019
B
BioDelivery Sciences International
Healthcare · Growth, 2019
A
Akorn
Healthcare · Growth, 2019
Frequently Asked Questions
New Rhein Healthcare focuses on Series B, Series C+ stage investments.
Related Investors
Adams Street Partners
Chicago, United States · 183 deals
Valor Equity Partners
Chicago, United States · 73 deals
Advanced Equities
Chicago, United States · 45 deals
Madison Dearborn Partners
Chicago, United States · 32 deals
Ares Management
Chicago, United States · 31 deals
Creation Investments Capital Management, LLC
Chicago, United States · 29 deals